| The medicinal perspective of 2, 4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review K Kajal, G Singh, T Pradhan, D Bhurta, V Monga Archiv der Pharmazie 355 (9), 2100517, 2022 | 18 | 2022 |
| Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). K Kajal, S Mondal, SK Wahan, P Patel Chemistry & Biodiversity, e202200847-e202200847, 2023 | 14 | 2023 |
| Recent green chemistry approaches for pyrimidine derivatives as a potential anti-cancer agent: An overview (2013–2023) K Kajal, R Shakya, M Rashid, V Nigam, BD Kurmi, GD Gupta, P Patel Sustainable Chemistry and Pharmacy 37, 101374, 2024 | 11 | 2024 |
| Current progress in the targeted therapy of breast cancer: Structure–activity correlation and docking studies (2015–2021) S Pandey, S Mondal, K Kajal, BD Kurmi, SK Verma, P Patel Archiv der Pharmazie 356 (8), 2200602, 2023 | 6 | 2023 |
| Corrigendum: The medicinal perspective of 2, 4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review K Kajal, G Singh, T Pradhan, D Bhurta, V Monga Archiv der Pharmazie 355 (9), 2270016, 2022 | 1 | 2022 |
| Current Trends in the Development of EGFR Inhibitors as Promising Anticancer Agents: Sar and Synthetic Studies from (2010-2020) S Mondal, KD Kajal, SK Wahan, BD Kurmi, P Patel Current Organic Chemistry 27 (1), 2-27, 2023 | | 2023 |
